Journal of Virology, March 2002, p. 2585-2594, Vol. 76, No. 6
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.6.2585-2594.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Departments of Neurology,3 Pediatrics,2 Medicine,8 Hematology and Oncology,5 Microbiology,1 Pharmacology,4 Immunology, University of Colorado Health Sciences Center,9 Neurology Service, Denver Veterans Affairs Medical Center, Denver, Colorado 80220,10 Program in Molecular Signal Transduction,6 Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 802067
Received 9 July 2001/ Accepted 30 November 2001
|
|
|---|
|
|
|---|
Reoviruses infect a variety of mammalian hosts and serve as an important experimental system for studying the molecular bases of viral pathogenesis (reviewed in reference 80). Reoviruses also provide a valuable model for studying virus-induced perturbations in cell cycle regulation, since reovirus infection has been associated with G1 arrest, G2/M arrest, and disruption of the mitotic spindle apparatus (see below). Inhibition of host cell DNA synthesis is one of the earliest cytopathic effects observed following serotype 3 reovirus infection in cultured cells (reviewed in reference 53). It was originally suggested that serotype 3 reovirus-induced inhibition of cellular proliferation resulted from inhibition of the initiation of DNA replication (14, 27, 68). However, the degree of cell culture synchronization prior to infection was either incomplete or not specified in these studies, impeding accurate identification of the cell cycle phase affected (14, 68).
Serotype 3 prototype strains type 3 Dearing (T3D) and type 3 Abney (T3A) inhibit cellular DNA synthesis to a greater extent than the serotype 1 prototype strain type 1 Lang (T1L) in a variety of cell lines (20, 23, 75, 82). Studies using T1L x T3D and T1L x T3A reassortant viruses indicate that the serotype 3 S1 gene is the primary determinant of differences in the capacity of reovirus strains to inhibit DNA synthesis (75, 82). The reovirus S1 gene segment is bicistronic, encoding the viral attachment protein,
1, and a non-virion-associated protein,
1s, from overlapping, alternative open reading frames (53).
Studies using purified recombinant serotype 3
1 protein and an anti-idiotype antibody (87.92.6) generated against the T3D
1-specific monoclonal antibody 9BG5 suggest that inhibition of DNA synthesis in some cells may result from engagement of a cell surface receptor by
1 (23, 70-72). For example, treatment of R1.1 thymoma cells with purified T3D
1 results in a reversible G1-to-S transition arrest (70, 71). The mechanism for T3D
1-induced G1-to-S arrest is not clear but may involve inhibition of p21ras (Ha-ras), since overexpression of Ha-ras prevents T3D
1-induced G1-to-S transition arrest (71, 72).
We have shown that reovirus infection inhibits cellular proliferation by inducing a G2/M phase cell cycle arrest in a variety of cell types (63). T3A and T3D induce G2/M phase cell cycle arrest to a greater extent than T1L (63). Like strain-specific differences in the capacity of reovirus to inhibit DNA synthesis (82), strain-specific differences in the capacity of reovirus to induce G2/M phase cell cycle arrest are determined by the serotype 3 S1 gene (63). The S1-encoded
1s protein is both necessary and sufficient to induce G2/M arrest, since a
1s-deficient reovirus mutant fails to induce G2/M arrest and inducible expression of
1s results in accumulation of cells in the G2/M phase of the cell cycle (63).
G2-to-M transition requires the formation and activation of the p34cdc2/cdk1 (cdc2)-cyclin B heterodimeric complex (reviewed in references 38 and 55). Activation of the cdc2-cyclin B complex is regulated by inhibitory phosphorylation of cdc2 (76). We showed that cdc2 kinase activity is inhibited following serotype 3, not serotype 1, reovirus infection (62). Inhibition of cdc2 kinase activity is, in part, due to serotype 3
1s-dependent phosphorylation of cdc2 (62). However, the pathway(s) leading to cdc2 kinase inhibition following serotype 3 reovirus infection remains unclear.
Since G2 phase arrest cannot easily be distinguished from M phase arrest by flow cytometry using DNA intercalating dyes, it is possible that both G2-to-M checkpoint arrest and mitotic spindle checkpoint arrest contribute to reovirus-induced G2/M phase cell cycle arrest. Electron microscopic studies have shown that reovirus particles align along parallel arrays of microtubules and have the capacity to bind microtubules in vitro (3). Serotype 3 reovirus particles associate with microtubules of the mitotic spindle apparatus in infected cells (15) and require microtubule stability for fast axonal transport (81). In addition to association with microtubules, reovirus infection results in progressive disruption and reorganization of the vimentin (intermediate) filament network (74). The binding of reovirus to microtubules and the disruption of vimentin filaments may lead to changes in microtubule tension or binding to the kinetochore. Reovirus-induced disruption of the microtubule-kinetochore association could lead to activation of the mitotic spindle checkpoint and M phase cell cycle arrest (2, 78).
Serotype 3 reovirus infection activates the cellular transcription factors NF-
B (4, 13) and c-Jun (P. Clarke, personal communication). Activation of transcription factors following reovirus infection suggests that gene expression is critical in reovirus-induced pathogenesis. To identify potential pathways leading to serotype 3 reovirus-induced inhibition of proliferation, we conducted experiments to investigate the transcriptional response following serotype 3 and serotype 1 reovirus infections. High-throughput screening of more than 12,000 genes using oligonucleotide microarrays has identified potential reovirus-induced signaling pathways involved in cell cycle control. Of the genes differentially expressed following reovirus infection, several encode regulators of the critical G2-to-M transition kinase cdc2.
|
|
|---|
cRNA target preparation and hybridization. Cells were harvested at 6, 12, and 24 h postinfection and washed with phosphate-buffered saline, and total RNA was isolated by using the RNeasy Mini Kit (Qiagen, Valencia, Calif.). Ten micrograms of RNA was converted to cDNA by using SuperScript Choice (Gibco-BRL), substituting high-performance liquid chromatography-purified T7-oligo-d(T)24 for random primers. Second-strand synthesis was performed using T4 DNA polymerase, and cDNA was isolated by phenol-chloroform extraction using phase lock gels. Isolated cDNA was in vitro transcribed by using the BioArray High Yield RNA Transcript Labeling Kit (Enzo Biochem, New York, N.Y.) supplied with biotin-labeled UTP and CTP to produce biotin-labeled cRNA. Labeled cRNA was isolated by using an RNeasy Mini Kit column (Qiagen) and quantified for purity and yield. cRNA was fragmented in 100 mM potassium acetate-30 mM magnesium acetate-40 mM Tris-acetate (pH 8.1) for 35 min at 94°C, and hybridization performance was analyzed by using Test 2 arrays (Affymetrix, Santa Clara, Calif.). Target cRNA was hybridized to the U95A microarray (Affymetrix) according to Affymetrix protocols. Briefly, 15 µg of fragmented cRNA was hybridized for 16 h at 45°C with constant rotation (60 rpm). Microarrays were washed and stained with streptavidin-conjugated phycoerythrin (SAPE) by using the Affymetrix GeneChip Fluidic Station 400. Staining intensity was antibody amplified by using a biotinylated anti-streptavidin antibody at a concentration of 3 µg per ml followed by a second SAPE stain and was visualized at 570 nm. All hybridization steps were performed at the University of Colorado Health Sciences Center (UCHSC) Cancer Center Microarray Facility.
Data analysis. Each gene on the U95A array is represented by 20 different 25-base cDNA oligonucleotides complementary to a cRNA target transcript (perfect match). As a hybridization specificity control, an oligonucleotide containing a single base substitution corresponding to each perfect-match cDNA oligonucleotide (mismatch) is represented on the array. The combination of perfect-match and mismatch cDNA oligonucleotides for each gene is termed a probe set. By using Affymetrix-defined absolute mathematical algorithms describing perfect-match and mismatch intensities, each gene was defined as absent or present and assigned a value. Binding intensity values were scaled to evaluate differential expression following reovirus infection. By using Affymetrix-defined comparison mathematical algorithms, a reovirus-induced transcript was classified as not changed, marginally increased, marginally decreased, increased, or decreased, and a fold change in expression was calculated. Nucleotide accession numbers for transcripts cited in the text that were not changed appear in Table 2. Since each condition was performed in duplicate, we used two additional criteria, as follows, to classify a gene as significantly up- or downregulated following reovirus infection. (i) Reovirus-induced expression of a gene at each time point must be classified as increased or marginally increased (or decreased or marginally decreased) in each virus-infected condition compared to each mock-infected condition. (ii) The mean fold change in reovirus-induced gene expression must be greater than 2. Mean transcriptional expression of a given gene at a given time point was calculated as the sum of the fold change in gene expression for each virus-infected condition compared to each mock-infected condition divided by 4. Standard errors in mean transcriptional expression of a gene were also calculated.
|
View this table: [in a new window] |
TABLE 2. Nucleotide accession numbers for genes mentioned in the text that were not changed following T3A or TIL infection
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Reovirus-induced alterations in expression of genes known to regulate the cell cycle
|
Reovirus-induced alterations in genes encoding proteins that regulate G1-to-S progression.
Treatment of specific cell types, including R1.1 thymoma cells, with purified T3D
1 protein leads to a reversible G1-to-S transition arrest that depends on the inhibition of Ha-ras (70-72). Ten genes encoding proteins that function at the G1-to-S transition were altered following serotype 3 reovirus infection. The level of Ha-ras gene expression was not changed following reovirus infection. Expression of the gene encoding N-ras was also not inhibited and was, in fact, increased 2.1-fold ± 0.2-fold in serotype 3 reovirus-infected cells at 24 h postinfection (Table 1).
The G1-to-S transition requires activation of cyclin-dependent kinases (cdk) (57). cdk2, -4, and -6 kinase activity results in phosphorylation of the retinoblastoma protein (pRb) and the pRb-related proteins p107 and p130. Phosphorylation of pRb leads to activation of the transcription factor E2F (31). The level of cdk4 gene expression was not changed following reovirus infection (Table 2). cdk2 and -6 were not represented on the U95A microarray. Levels of pRb, p107, p130, and E2F1, -2, -4, -5, and -6 gene expression were not changed following reovirus infection (Table 2), except for the transcript encoding E2F6, which was upregulated 2.1-fold ± 0.1-fold following T1L infection (Table 1). Activation of cdk2, -4, or -6 requires binding to cyclin E or cyclin D (31). Cyclin E expression was reduced 2.8-fold ± 0.1-fold in serotype 3 reovirus-infected cells. However, the level of cyclin E2 (a cyclin E isoform) gene expression was increased 2.1-fold ± 0.2-fold in serotype 3 reovirus-infected cells (Table 1). Levels of cyclin D1, -2, and -3 expression were not changed following reovirus infection (Table 2).
Activation of cdk2 depends on its phosphorylation state (57). The level of protein phosphatase 2C (PP2C) gene expression at 24 h after infection with T3A was 5.3-fold ± 0.4-fold greater than that for a mock-infected control. cdk-cyclin complex activity is known to be inhibited by cdk inhibitors (CDKI) (29, 31). Levels of CDKI expression, including p21WAF1/CIP1, p27KIP1, p57KIP2, p16INK4a, p15INK4b, and p19INK4d were not changed following reovirus infection (Table 2). Since active cdk2, -4, or -6 kinase results in E2F-dependent transcription, the transcriptional level of E2F-responsive genes necessary for the G1-to-S transition, including cyclin E, cyclin A, cdc2, cdc25C, p21WAF1/CIP1, c-myc, B-myb, p107, E2F1, E2F2, dihydrofolate reductase, thymidine kinase, DNA polymerase
, histone H2A, and cdc6, serve as a measure of cdk2, -4, or -6 kinase activity (26). Levels of these E2F-responsive transcripts were not changed following reovirus infection except for cyclin E, c-myc, and DNA polymerase
, which were downregulated 2.8-fold ± 0.1-fold, 2.0-fold ± 0.0-fold, and 2.5-fold ± 0.2-fold following serotype 3 reovirus infection, respectively, and histone H2A and cdc2, which were upregulated 2.0-fold ± 0.1-fold or 2.2-fold ± 0.1-fold and 1.8-fold in serotype 3 reovirus compared to mock-infected cells. The failure to detect a coherent pattern of gene expression encoding key G1-to-S checkpoint control proteins is consistent with our observation that reovirus infection does not induce G1 arrest in HEK293 cells. However, we did find changes in the expression of genes encoding histones, cyclin E and E2, and some E2F-responsive transcripts following serotype 3 reovirus infection.
Reovirus-induced alterations in genes encoding proteins that regulate the G2-to-M progression. We have previously shown that serotype 3 reovirus-induced G2/M phase cell cycle arrest is due to inhibitory phosphorylation of cdc2 (62). Eleven genes encoding proteins that function at the G2-to-M transition were altered following serotype 3 reovirus infection. These changes were among the earliest changes in gene expression identified in serotype 3 reovirus-infected cells. The level of cdc2 gene expression at 24 h post-T3A infection was 1.8-fold greater than that in a mock-infected control. We have not reproducibly detected changes in levels of cdc2 protein in reovirus-infected cells; however we have consistently found an increase in the proportion of hyperphosphorylated cdc2 following serotype 3 reovirus infection (62). An increase in cdc2 phosphorylation could result from an increase in wee1 kinase activity, which directly phosphorylates and inactivates cdc2 (60). wee1 was determined to be upregulated at 24 h postinfection by using the U95A microarray (Table 1). Levels of wee1 gene expression at 24 h post-T3A infection were 2.4-fold ± 0.1-fold (for accession number U10564) and 2.5-fold ± 0.1-fold (for accession number X62048) greater than those for a mock-infected control. Levels of wee1 gene expression at 24 h post-T1L infection were 1.9-fold ± 0.1-fold (for accession number U10564) and 2.0-fold ± 0.1-fold (for accession number X62048) greater than those for a mock-infected control. The increases in wee1 gene expression following T3A and T1L infection were confirmed by RT-PCR and were 2.3- and 2.4-fold greater, respectively, than those for a mock-infected control at 24 h postinfection (Fig. 1). RT-PCR analysis of UV-inactivated T3A-infected cells, demonstrated a small but measurable increase in wee1 transcripts compared that for to mock-infected cells (a 1.6-fold increase), indicating that active viral replication is not necessary but may augment the expression of wee1 in reovirus-infected cells (Fig. 1). Increased levels of wee1 kinase may result in inhibitory phosphorylation of cdc2 following serotype 3 reovirus infection, but increases in wee1 are not sufficient for serotype 3 reovirus-induced phosphorylation of cdc2, since T1L infection results in similar increases in wee1 gene expression.
![]() ![]() View larger version (74K): [in a new window] |
FIG. 1. wee1, chk1, and GADD45 transcripts are increased following reovirus infection. (a) HEK293 cells were either mock infected or infected with T3A, T1L, or UV-inactivated T3A at an MOI of 100 PFU per cell. mRNA was collected at 24 h postinfection and analyzed for chk1, wee1, and GADD45 transcripts by RT-PCR to confirm microarray analyses and also to assess the importance of replication competence for the observed changes in gene expression. ß-Actin was used as a control in each RT-PCR to ensure matched total mRNA and equivalent amplication conditions for each experimental sample. (b) Quantitative densitometric analysis of specific mRNA abundance in each sample.
|
In addition to the inhibition of cdc2 by phosphorylation, serotype 3 reovirus-induced G2/M phase cell cycle arrest could result from dissociation of cdc2 from cyclin B. The level of cyclin B gene expression was not changed following reovirus infection (Table 2), consistent with our studies suggesting that changes in the level of cyclin B protein are not responsible for reovirus-induced G2-to-M transition arrest (62).
GADD45 is known to inhibit cdc2 kinase activity by physically dissociating cdc2 kinase from cyclin B (87). To determine whether GADD45 could be responsible for reovirus-induced inactivation of cdc2, we analyzed the transcriptional expression of GADD45 following serotype 3 reovirus infection. Levels of GADD45 gene expression at 12 and 24 h after infection with T3A were 3.3-fold ± 0.2-fold and 4.9-fold ± 0.1-fold greater than those for a mock-infected control, respectively (Table 1). The increase in GADD45 gene expression following T3A infection was confirmed by RT-PCR and was 4.5-fold greater than that for a mock-infected control at 24 h postinfection (Fig. 1). The level of GADD45 gene expression at 24 h after infection with T1L was 4.4-fold ± 0.1-fold greater than that for a mock-infected control, and this increase was confirmed by RT-PCR (5.2-fold increase [Fig. 1]). A small but measurable increase in the level of GADD 45 transcripts was noted by RT-PCR analysis in cells infected with UV-inactivated T3A compared to mock-infected cells (1.3-fold increase [Fig. 1]). This suggests that increased levels of GADD45 may result in inhibition of cdc2 by physically dissociating cdc2 from cyclin B following serotype 3 reovirus infection, but increases in GADD45 are not sufficient for serotype 3 reovirus-induced phosphorylation of cdc2, since T1L infection results in a similar increase in GADD45 gene expression. Thus, we found that reovirus infection induces changes in expression levels of genes encoding key proteins regulating cdc2 kinase activity, including wee1, chk1, and GADD45, which is consistent with the findings of our previous studies suggesting a central role for cdc2 inhibition in serotype 3 reovirus-induced G2/M phase cell cycle arrest (63).
Reovirus-induced alterations in genes encoding proteins that regulate mitotic spindle checkpoint signaling. Reovirus particles are capable of binding microtubules, and infection results in progressive disruption of vimentin filaments. Changes in microtubule tension or binding to the kinetochore could lead to reovirus-induced mitotic arrest. Four genes encoding proteins that function at the mitotic spindle checkpoint were altered following reovirus infection. The transcriptional levels of mitotic spindle checkpoint components that monitor spindle abnormalities, including MAD2, MAD3, and BUB1, were not changed following reovirus-infection (Table 2). The level of BUB3 gene expression at 24 h after infection with T3A was 2.2-fold ± 0.1-fold greater than that for a mock-infected control (Table 1). Activation of the mitotic spindle checkpoint leads to inhibition of the anaphase-promoting complex (APC) and M phase cell cycle arrest (2, 78). Expression of the gene encoding Nuc2, an APC component, was 2.1-fold ± 0.2-fold greater than that for a mock-infected control (Table 1). These results suggest that serotype 3 reovirus-induced alterations in gene expression may induce M phase cell cycle arrest.
|
|
|---|
G1-to-S checkpoint: reovirus-induced alterations in G1-to-S restriction checkpoint control.
Treatment with purified T3D
1 protein leads to a reversible G1-to-S phase transition arrest in R1.1 thymoma cells that is dependent on Ha-ras inhibition (70-72). However, G1-to-S arrest is not a universal feature of reovirus infection and does not occur in reovirus-infected HEK293 cells (63). We were unable to detect changes in expression of p21ras-related genes involved in G1-to-S regulation, and we found that gene expression of the p21ras isoform, N-ras, was selectively increased following serotype 3 reovirus infection.
G1-to-S transition arrest following serotype 3 reovirus infection could result from inactivation of the G1-to-S cyclin dependent kinase cdk2, -4, or -6 by the protein phosphatase PP2C-
. PP2C-
is known to dephosphorylate activating phosphates on cdk2 (9), which may result in inhibition of cdk2 kinase activity. Decreased expression of the cdk2 regulatory cyclin, cyclin E, was counterbalanced by an increase in the expression of the cyclin E isoform, cyclin E2, suggesting that G1 cyclin expression does not play a significant role in regulating serotype 3 reovirus-induced G1-to-S progression. Alterations in histone synthesis and alterations in the relative levels of histone proteins could alter G1-to-S progression, but no clear model has been elucidated (19). Collectively, these findings indicate that serotype 3 reovirus-induced alterations in gene expression are not consistent with G1-to-S arrest in HEK293 cells.
G2-to-M checkpoint: reovirus-induced inhibition of cdc2 by phosphorylation. Serotype 3 reovirus-induced G2/M phase cell cycle arrest results from a reduction in cdc2 kinase activity due to inhibitory phosphorylation, which has been demonstrated in infection of multiple cell lines, including HEK293, MDCK, C127, and HeLa cells (62). An increase in hyperphosphorylated cdc2 could be due either to increases in cdc2-specific kinase activity or to decreases in cdc2-specific phosphatase activity, or to both. The kinases wee1 and myt1 and the phosphatase cdc25C regulate the phosphorylation state of cdc2 (reviewed in reference 38). Following serotype 3 reovirus infection, levels of wee1 transcripts are elevated, suggesting that this kinase may play a role in inhibiting cdc2 (Fig. 2). However, an elevation in wee1 transcript levels is not sufficient for serotype 3 reovirus-induced inhibitory phosphorylation of cdc2, since the transcript encoding wee1 kinase is similarly upregulated following T1L infection. The activity of the cdc2-specific phosphatase cdc25C is regulated by phosphorylation. Hyperphosphorylation of cdc25C results in active phosphatase activity capable of removing inhibitory phosphates from cdc2 kinase (reviewed in reference 38). Following reovirus infection, cdc25C is inhibited by dephosphorylation (62). It is suggested that the HIV Vpr protein can inhibit cdc2 kinase activity (30, 64) through mechanisms requiring wee1 and involving the inactivation of cdc25C (35, 48).
![]() View larger version (15K): [in a new window] |
FIG. 2. Proposed model for serotype 3 reovirus-induced G2-to-M transition arrest. cdc2 kinase activity is required for entry into mitosis. Active cdc2 kinase is complexed with cyclin B and dephosphorylated at Thr14/Tyr15. Following reovirus infection, cdc2 is inhibited, in part, by phosphorylation. The increase in phosphorylated cdc2 may be due to upregulation of the kinases chk1 and wee1 and/or localization to the nucleus of the phosphatase PP2A, which can inhibit the cdc2-activating phosphatase cdc25C. cdc2 kinase activity may also be inhibited by dissociation of cyclin B by GADD45. Arrows indicate activation; blunted lines indicate inhibition.
|
cdc25C activity is also inhibited following phosphorylation by the kinases chk1 and chk2 (22, 69). Phosphorylation of cdc25C on Ser-216 by chk1 or chk2 leads to 14-3-3 protein binding, which results in sequestration of cdc25C into the cytoplasm (47, 61). Export to the cytoplasm physically separates cdc25C from cdc2 kinase. We have found that reovirus infection is associated with increased expression of chk1, suggesting that this kinase plays a role in reovirus-induced inhibition of cdc25C (Fig. 2). chk1 kinase activity is also suggested to regulate wee1 subcellular localization, such that cdc2 kinase is phosphorylated and inactivated (56) (Fig. 2). This suggests that serotype 3 reovirus infection may selectively increase the level of chk1 kinase activity to modulate the activities of kinases and phosphatases directly responsible for regulating cdc2 activity.
G2-to-M checkpoint: reovirus-induced inhibition of cdc2 by physical dissociation from cyclin B. An alternative mechanism for cdc2 inhibition is by physical interaction with GADD45. GADD45 inhibits cdc2 kinase by physically dissociating cdc2 from cyclin B (83, 87). Physical dissociation of cdc2 kinase from its regulatory cyclin results in elimination of cdc2 kinase activity and G2-to-M checkpoint arrest (24, 55). Serotype 3 reovirus induces an increase in GADD45 expression, suggesting that GADD45 plays a role in reovirus-induced G2-to-M checkpoint arrest (Fig. 2). However, an elevation in GADD45 transcript levels is not sufficient for serotype 3 reovirus-induced inhibition of cdc2 kinase activity, since the transcript encoding GADD45 is similarly upregulated following T1L infection. Interestingly, it is possible that GADD45-induced inhibition of cdc2 kinase activity results in accumulation of cells in the G2/M phase of the cell cycle following infection with a herpes simplex virus (HSV) restricted to expressing the infected-cell polypeptide ICP0, since this virus induces an increase in GADD45 protein levels (34). The capacity of GADD45 to regulate cdc2 activity is a function of protein concentration (83). GADD45 transcription is regulated by p53 (41, 87) and Brca1 (28, 39). We have preliminary data suggesting that serotype 3 reovirus infection may result in increased expression of Brca1 protein. Reovirus-induced increases in Brca1 activity may result from changes in the activity of ATM or ATM-related kinases (46). Although we did not detect changes in expression of the gene encoding ATM, the expression of FRP1, a kinase with significant homology to ATM kinases (11), was selectively increased following serotype 3 reovirus infection.
The data presented in this report and our previous studies are consistent with a model in which reovirus-induced phosphorylation of cdc2 results in G2/M phase cell cycle arrest that is dependent on
1s expression (63).
1s is a highly basic protein (16, 17) that is present in the nuclei of serotype 3-infected cells (7, 67), where it could directly interact with cdc2 or proteins regulating cdc2 kinase activity. However, the role of
1s in serotype 3 reovirus-induced G2/M phase cell cycle arrest has not yet been determined.
Mitotic spindle checkpoint: reovirus-induced alterations in spindle checkpoint signaling. Reovirus-induced disruption of the microtubule-kinetochore association may contribute to G2/M arrest by activating the mitotic spindle checkpoint, which inhibits the APC and results in M phase arrest (2, 78). Selective expression of several genes encoding proteins with putative roles in regulating the mitotic spindle checkpoint were altered following serotype 3 reovirus infection. For example, Bub3 is an integral component of mitotic spindle checkpoint signaling, localizes to unattached kinetochores, and phosphorylates and complexes with Bub1 (6, 40, 66, 79). The functions of MPP11 and HZWINT1 are not completely understood but have been speculated to contribute to mitotic spindle checkpoint regulation, since they localize to mitotic structures, including kinetochores (49, 65, 77). These results suggest that deregulation of mitotic spindle checkpoint proteins may also contribute to serotype 3 reovirus-induced G2/M phase cell cycle arrest.
Other proteins functioning in G2 or M. Several genes encoding proteins that influence both the G2-to-M and mitotic spindle checkpoints were selectively differentially regulated following serotype 3 reovirus infection. For example, polo-like kinase activity is important in regulating G2-to-M transition events by activating cdc25C and in regulating M phase events including APC regulation, centrosome maturation, and bipolar spindle formation (25, 54). SAK, a polo-like kinase (36), was found to be upregulated following serotype 3 reovirus infection; however, the role of SAK in cell cycle regulation is not clear. Interestingly, expression of murine SAK-a is cell cycle regulated, with levels peaking in M phase, which is consistent with a role in the latter portion of the cell cycle (21). This suggests that serotype 3 reovirus may perturb both the G2-to-M transition and the mitotic spindle checkpoint to ensure host cell cycle arrest in the G2/M phase.
Serotype 3 reovirus infection also selectively altered the expression of genes encoding proteins with cdc2-related serine/threonine kinase activity, including C-2k (5) and PCTAIRE-2 (33). This suggests that serotype 3 reovirus may require cdc2-like kinase activity to posttranslationally modify a viral protein in a manner similar to the phosphorylation of varicella-zoster virus glycoprotein gI (84), Epstein-Barr virus EBNA-LP (43), hepatitis E virus ORF3 (86), and herpes simplex virus ICP0 (1) by cdc2. Alternatively, cdc2-like kinase activity may be responsible for alterations in cytoskeletal structure following serotype 3 reovirus infection. As discussed earlier, reovirus infection leads to disruption and reorganization of vimentin filaments into viral inclusions. Vimentin organization is regulated by cdc2-related kinase activity (10). PCTAIRE-2 kinase activity may regulate cytoskeletal protein distribution (33). Thus, alterations in PCTAIRE-2 and Trap (tudor repeat associator with PCTAIRE-2 [32]) following reovirus infection may lead to cytoskeletal changes necessary for viral inclusion formation. These results suggest that the reovirus life cycle may require modulation of cdc2-like kinase activity.
The present experiments shed light on the kinetics of key cellular processes that may directly influence reovirus-induced G2/M arrest. The lack of differential expression of key transcripts prior to 12 h postinfection is consistent with prior findings, which showed no alteration in the activities of several key regulators of cell cycle progression (including cdc2 kinase) at 6 h postinfection (62). It is important to note that the lack of detectable altered gene expression at 6 h postinfection in these experiments does not preclude either early activation of cell cycle regulators at the protein level or altered expression of cell cycle-regulatory genes not represented on the U95A microarray. It is interesting that UV-inactivated (replication-incompetent) virus induced small but detectable changes in gene expression in the direction of those seen with infectious virus. This suggests that while viral replication may not be required, it substantially augments the expression of cellular regulators of cell cycle progression. Since the reovirus replication cycle is approximately 24 h in HEK293 cells, the requirement for viral replication for maximal alteration in gene expression may account for the lack of detectable alterations at the earliest time point postinfection.
In conclusion, reovirus infection alters a limited subset of transcripts encoding proteins that function to regulate cell cycle progression. Transcripts encoding proteins that function at the G1-to-S, G2-to-M, and mitotic spindle checkpoints were altered following serotype 3 reovirus infection. Of this group, genes encoding proteins regulating the G2-to-M cell cycle transition were among the earliest to show changes in expression. This is consistent with the findings of our previous studies indicating that serotype 3 reovirus infection of HEK293 cells induces a G2/M phase cell cycle arrest (63). We recently showed that G2/M arrest results from inhibition of the key G2-to-M transition kinase cdc2 (62). Consistent with these findings, we found changes in expression of kinases, phosphatases, and GADD proteins that directly and indirectly influence cdc2 kinase activity. These results have enabled us to provide a hypothetical model for modulation of cdc2 kinase activity in serotype 3 reovirus-infected cells.
This work was supported by Public Health Service award AG14071 from the National Institute on Aging, Merit and REAP grants from the Department of Veterans Affairs, a U.S. Army Medical Research Acquisition Activity Grant (DAMD17-98-1-8614) (to K.L.T.), and an Infectious Diseases Society of America Young Investigator Award (to R.L.D.).
|
|
|---|
and ß2 isoforms. J. Biol. Chem. 275:34744-34749.
B. J. Virol. 74:2981-2989.
1s-dependent G2/M phase cell cycle arrest is associated with inhibition of p34cdc2. J. Virol. 75:7429-7434.
1s and occurs in the absence of apoptosis. J. Virol. 74:9562-9570.
1s-null mutant. J. Virol. 72:8597-8604.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»